(Q37559585)

21 August 2017

1 reference

title

Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development (English)

1 reference

21 August 2017

Steven M Rowe

1

1 reference

PubMed ID

19627168

21 August 2017

John P Clancy

series ordinal

2

1 reference

21 August 2017

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

23

1 reference

21 August 2017

3

1 reference

21 August 2017

165-174

1 reference

https://scigraph.springernature.com/pub.10.2165/00063030-200923030-00003

21 August 2017

0 references

cites work

Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200923030-00003

Crossref

reference URL

Release factors and their role as decoding proteins: specificity and fidelity for termination of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200923030-00003

Crossref

reference URL

Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200923030-00003

Crossref

reference URL

10.2165/00063030-200923030-00003

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

19627168

Dimensions Publication ID

21 August 2017

0 references

1 reference

PubMed ID

19627168